Dr. Erin E. Katz, MD

Dr. Katz practices at Riverside Medical Clinic - Temescal Valley in Corona, California.

Dr. Katz's NPI, 1447296090, was assigned on June 21, 2006. Dr. Katz graduated from St. George's University School of Medicine in 1998. Dr. Katz holds Florida license ME89318.

Dr. Katz's primary practice is Riverside Medical Clinic - Temescal Valley, at 21634 Retreat Pkwy, Corona, CA 92883 in Riverside County. The practice phone is (951) 683-6370.

Dr. Katz's primary practice is Riverside Medical Clinic - Temescal Valley in Corona, California. Dr. Katz is also affiliated with Corona Regional Medical Center. The medical group on file is Riverside Medical Clinic. Dmand AI also links Dr. Katz to 2 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Katz practices, 4 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Katz's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Katz is board certified in urology by the American Board of Urology. Dmand AI has Dr. Katz's licenses on file in 5 states: Florida, Maine, California, Wisconsin and Illinois.

Dmand AI lists bladder disease, enlarged prostate, enlarged prostate transurethral surgery (TURP), erectile dysfunction, kidney cysts, kidney stone disease, pelvic prolapse and testicular dysfunction among the conditions Dr. Katz treats.

CMS data shows 4,120 Medicare services from Dr. Katz across 17 procedure codes in 2024, for 350 Medicare patients. Medicare paid $98,482 for them.

CMS counts 350 Medicare patients who saw Dr. Katz in 2024. The largest group is 65 to 74, with 144 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 25% are also on Medicaid. Their average risk score is 1.74, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Katz's median patient age at 68, with 66% women.

In 2024, Dr. Katz wrote 3,003 Medicare Part D claims for 688 patients. 91% of them were for generic drugs. CMS names the drug for 2,841 of them, across 30 drugs with 11 or more claims each, at $195,067 in total drug cost. In 2023, CMS named 2,508 claims across 28 drugs.

Dr. Katz accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Prostate resection: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 6 papers to Dr. Katz. The most frequent topics are Urinary Incontinence. Dr. Katz has published most often in Urology. Dr. Katz's most frequent co-authors are Gregory T. Bales and David E. Rapp, MD.

CMS Open Payments shows 269 general payments to Dr. Katz from 27 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 68% of the total. NeoTract Inc. paid the most, $1,495.

Dmand AI lists 12 awards for Dr. Katz, most recently CMS Stage 1 2012 in 2011.

Dr. Katz graduated from St. George's University School of Medicine in 1998.

Dr. Katz is in network with 14 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.